CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-09-01 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −2,146 | 35,281 | ||
| 2017-09-01 | Schenkein David P Chief Executive Officer | Option exercise | +6,000 | $0.30 | $2K | 6,000 |
| 2017-09-01 | Schenkein David P Chief Executive Officer | Sale | −6,000 | $62.20 | $373K | 0 |
| 2017-09-01 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −6,000 | 153,656 | ||
| 2017-08-23 | Cantley Lewis Clayton Jr. Director | Sale | −500 | $57.09 | $29K | 87,894 |
| 2017-08-23 | Cantley Lewis Clayton Jr. Director | Sale | −500 | $57.09 | $29K | 87,934 |
| 2017-08-23 | Cantley Lewis Clayton Jr. Director | Sale | −500 | $57.07 | $29K | 87,394 |
| 2017-08-23 | Cantley Lewis Clayton Jr. Director | Sale | −500 | $57.07 | $29K | 87,434 |
| 2017-08-22 | Cantley Lewis Clayton Jr. Director | Sale | −500 | $56.63 | $28K | 88,894 |
| 2017-08-22 | Cantley Lewis Clayton Jr. Director | Sale | −500 | $56.63 | $28K | 88,934 |
| 2017-08-22 | Cantley Lewis Clayton Jr. Director | Sale | −500 | $56.61 | $28K | 88,394 |
| 2017-08-22 | Cantley Lewis Clayton Jr. Director | Sale | −500 | $56.61 | $28K | 88,434 |
| 2017-08-02 | Biller Scott Chief Scientific Officer | Sale | −21,000 | $60.06 | $1.3M | 25,470 |
| 2017-08-02 | Schenkein David P Chief Executive Officer | Option exercise | +24,000 | $0.30 | $7K | 24,000 |
| 2017-08-02 | Schenkein David P Chief Executive Officer | Sale | −24,000 | $60.55 | $1.5M | 0 |
| 2017-08-02 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −24,000 | 159,656 | ||
| 2017-08-01 | Biller Scott Chief Scientific Officer | Option exercise | +2,146 | $9.05 | $19K | 8,410 |
| 2017-08-01 | Biller Scott Chief Scientific Officer | Sale | −2,146 | $55.05 | $118K | 6,264 |
| 2017-08-01 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −2,146 | 37,427 | ||
| 2017-08-01 | Schenkein David P Chief Executive Officer | Option exercise | +3,000 | $0.30 | $908 | 3,000 |
Page 73 of 80 · 1,590 trades